Found: 35
Select item for more details and to access through your institution.
Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 6, p. 365, doi. 10.1111/ajco.12681
- By:
- Publication type:
- Article
Clinical significance of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 gene polymorphisms in patients with gastrointestinal stromal tumors.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2014, v. 10, n. 2, p. e40, doi. 10.1111/ajco.12068
- By:
- Publication type:
- Article
Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 223, doi. 10.4143/crt.2018.073
- By:
- Publication type:
- Article
Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05).
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1252, doi. 10.4143/crt.2017.438
- By:
- Publication type:
- Article
Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 499, doi. 10.4143/crt.2015.089
- By:
- Publication type:
- Article
Metachronous Double Primary Cancer after Treatment of Breast Cancer.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 1, p. 64, doi. 10.4143/crt.2013.215
- By:
- Publication type:
- Article
A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy.
- Published in:
- Cancer Research & Treatment, 2014, v. 46, n. 1, p. 19, doi. 10.4143/crt.2014.46.1.19
- By:
- Publication type:
- Article
Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement.
- Published in:
- Cancer Research & Treatment, 2013, v. 45, n. 2, p. 112, doi. 10.4143/crt.2013.45.2.112
- By:
- Publication type:
- Article
Metachronous Double Primary Cancer after Diagnosis of Gastric Cancer.
- Published in:
- Cancer Research & Treatment, 2012, v. 44, n. 3, p. 173, doi. 10.4143/crt.2012.44.3.173
- By:
- Publication type:
- Article
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1164, doi. 10.1007/s10637-011-9651-3
- By:
- Publication type:
- Article
The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study.
- Published in:
- Supportive Care in Cancer, 2011, v. 19, n. 2, p. 297, doi. 10.1007/s00520-010-0825-x
- By:
- Publication type:
- Article
The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2002, v. 29, n. 5, p. 591, doi. 10.1007/s00259-001-0747-4
- By:
- Publication type:
- Article
Palliative Chemotherapy Preferences and Factors that Influence Patient Choice in Incurable Advanced Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2008, v. 38, n. 1, p. 64, doi. 10.1093/jjco/hym147
- By:
- Publication type:
- Article
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 7, p. 725, doi. 10.1007/s00277-010-0910-8
- By:
- Publication type:
- Article
Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
- Published in:
- Annals of Hematology, 2006, v. 85, n. 9, p. 575, doi. 10.1007/s00277-006-0127-z
- By:
- Publication type:
- Article
Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 1, p. 31, doi. 10.1007/s00280-009-1130-6
- By:
- Publication type:
- Article
Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 4, p. 641, doi. 10.1007/s00280-009-1069-7
- By:
- Publication type:
- Article
Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 317, doi. 10.1007/s00280-008-0873-9
- By:
- Publication type:
- Article
TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 355, doi. 10.1007/s00280-008-0879-3
- By:
- Publication type:
- Article
A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1083, doi. 10.1007/s00280-008-0818-3
- By:
- Publication type:
- Article
A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 763, doi. 10.1007/s00280-007-0661-y
- By:
- Publication type:
- Article
Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 863, doi. 10.1007/s00280-007-0433-8
- By:
- Publication type:
- Article
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 819, doi. 10.1007/s10120-018-0806-1
- By:
- Publication type:
- Article
Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 4, p. 528, doi. 10.3109/0284186X.2011.636753
- By:
- Publication type:
- Article
Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01).
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 24, p. 6234, doi. 10.1002/cncr.27630
- By:
- Publication type:
- Article
A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First‐line Therapy (KCSG ST10‐01).
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 18, doi. 10.1634/theoncologist.2018-0142
- By:
- Publication type:
- Article
Clinical Trial Results. A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1128, doi. 10.1634/theoncologist.2014-0305
- By:
- Publication type:
- Article
Correction to: The impact of caregiver's role preference on decisional conflicts and psychiatric distresses in decision making to help caregiver's disclosure of terminal disease status.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
The impact of caregiver's role preference on decisional conflicts and psychiatric distresses in decision making to help caregiver's disclosure of terminal disease status.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Triplet cytotoxic chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced pancreatic cancer.
- Published in:
- Oncology Letters, 2015, v. 10, n. 2, p. 1204, doi. 10.3892/ol.2015.3347
- By:
- Publication type:
- Article
Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.
- Published in:
- Cancer Science, 2010, v. 101, n. 3, p. 793, doi. 10.1111/j.1349-7006.2009.01447.x
- By:
- Publication type:
- Article
Prevalence and Management of Pain by Different Age Groups of Korean Cancer Patients.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article